4Ts Score for Heparin-Induced Thrombocytopenia

4Ts Score for Heparin-Induced Thrombocytopenia

Estimates probability of HIT in patients with thrombocytopenia

4Ts Score for Heparin-Induced Thrombocytopenia

4Ts Score for Heparin-Induced Thrombocytopenia

Estimates probability of HIT in patients with thrombocytopenia

Thrombocytopenia
Degree of platelet count drop
Timing of Platelet Count Drop
Relative to heparin exposure
Thrombosis or Other Sequelae
Presence of new thrombosis or complications
Other Causes for Thrombocytopenia
Exclusion of alternative explanations
4Ts Score 0Low probability (≤ 3)
0/4 answered · tap options to update (0-8)

Instructions

The 4Ts Score helps estimate the probability of heparin-induced thrombocytopenia. It considers platelet count fall, timing of onset, thrombosis, and other causes. A higher score suggests greater suspicion for HIT.

Overview
When to use
Why use
Evidences

Interpretation

Total Score

Probability of HIT

0–3

Low

4–5

Intermediate

6–8

High

 The 4Ts is a pretest clinical score for suspected heparin-induced thrombocytopenia (HIT) based on Thrombocytopenia, Timing, Thrombosis/other sequelae, and oTher causes; total 0–8 with bands: low (0–3), intermediate (4–5), high (6–8)
https://pmc.ncbi.nlm.nih.gov/articles/PMC3501714/

 

ASH 2018 guidelines recommend using the 4Ts rather than gestalt to estimate pretest probability; for intermediate/high scores, discontinue heparin, start a non-heparin anticoagulant (intensity per bleeding risk), and send an immunoassay with functional testing if positive; do not test or treat for HIT when 4Ts is low
https://ashpublications.org/bloodadvances/article/2/22/3360/16129/American-Society-of-Hematology-2018-guidelines-for

 

A 2024 diagnostic study (n=1,318) found nontrivial misclassification in real-world practice: 4Ts false negatives 9.0% and false positives 49.0%; the combined algorithm (4Ts→immunoassay) had 13.5% false negatives but reduced false positives to 4.1%, underscoring the need for accurate scoring and appropriate lab testing
https://pmc.ncbi.nlm.nih.gov/articles/PMC10966416/

Overview
When to use
Why use
Evidences

The 4Ts Score is a clinical prediction tool developed to assess the pretest probability of heparin-induced thrombocytopenia, a rare but serious immune-mediated adverse effect of heparin therapy. HIT occurs when antibodies form against platelet factor 4 (PF4)–heparin complexes, leading to platelet activation, thrombocytopenia, and a markedly increased risk of thrombosis. Because thrombosis rather than bleeding is the major complication, early recognition is critical.

The 4Ts mnemonic reflects the four key clinical domains:

  1. Thrombocytopenia – degree of platelet count fall.

  2. Timing – when the fall occurs relative to heparin exposure.

  3. Thrombosis – presence of new clot or skin necrosis.

  4. oTher causes – possible alternative explanations.

Each domain is scored from 0 to 2, resulting in a total from 0 to 8. Patients are then classified as low, intermediate, or high probability for HIT. This score is primarily used as an initial screening tool. A low score has a high negative predictive value and can safely exclude HIT without further testing, while intermediate or high scores warrant laboratory confirmation such as PF4 ELISA or serotonin release assay.

Overview
When to use
Why use
Evidences

Interpretation

Total Score

Probability of HIT

0–3

Low

4–5

Intermediate

6–8

High

 The 4Ts is a pretest clinical score for suspected heparin-induced thrombocytopenia (HIT) based on Thrombocytopenia, Timing, Thrombosis/other sequelae, and oTher causes; total 0–8 with bands: low (0–3), intermediate (4–5), high (6–8)
https://pmc.ncbi.nlm.nih.gov/articles/PMC3501714/

 

ASH 2018 guidelines recommend using the 4Ts rather than gestalt to estimate pretest probability; for intermediate/high scores, discontinue heparin, start a non-heparin anticoagulant (intensity per bleeding risk), and send an immunoassay with functional testing if positive; do not test or treat for HIT when 4Ts is low
https://ashpublications.org/bloodadvances/article/2/22/3360/16129/American-Society-of-Hematology-2018-guidelines-for

 

A 2024 diagnostic study (n=1,318) found nontrivial misclassification in real-world practice: 4Ts false negatives 9.0% and false positives 49.0%; the combined algorithm (4Ts→immunoassay) had 13.5% false negatives but reduced false positives to 4.1%, underscoring the need for accurate scoring and appropriate lab testing
https://pmc.ncbi.nlm.nih.gov/articles/PMC10966416/

Frequently Asked Questions

Features and Services FAQs

Discover the full range of features and services we offer and how to use them.

What does the 4Ts Score stand for?+
Can a low score completely rule out HIT?+
Do intermediate or high scores confirm HIT?+
Is the score useful for both UFH and LMWH?+
How quickly should heparin be stopped if suspicion is high?+
Can thrombosis occur even if platelet counts are only moderately reduced?+

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.